Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea · Delayed Price · Currency is KRW 3,890.00
-60.00 (-1.52%)
At close: May 29, 2026
Genesystem Market Cap
Genesystem has a market cap or net worth of 32.23 billion as of May 29, 2026. Its market cap has decreased by -54.76% in one year.
Market Cap
32.23B
Enterprise Value
30.95B
Revenue
647.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,890.00
Market Cap Chart
Since May 26, 2021, Genesystem's market cap has decreased from 118.51B to 32.23B, a decrease of -72.80%. That is a compound annual growth rate of -22.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 32.23B | 15.27% |
| Dec 30, 2025 | 27.96B | -52.89% |
| Dec 30, 2024 | 59.36B | -8.92% |
| Dec 28, 2023 | 65.17B | 12.35% |
| Dec 29, 2022 | 58.00B | -26.36% |
| Dec 30, 2021 | 78.77B | -33.54% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dynamic solution | 77.14B |
| QuantaMatrix | 63.22B |
| DRGEM | 55.46B |
| Noul Co.,Ltd. | 53.34B |
| Genoray | 49.99B |
| JPI Healthcare | 46.77B |
| MEKICS CO., | 36.11B |
| UXN Co., Ltd. | 28.49B |